These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27255695)

  • 21. Structural and mechanistic insights into Hsp104 function revealed by synchrotron X-ray footprinting.
    Sweeny EA; Tariq A; Gurpinar E; Go MS; Sochor MA; Kan ZY; Mayne L; Englander SW; Shorter J
    J Biol Chem; 2020 Feb; 295(6):1517-1538. PubMed ID: 31882541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suramin inhibits Hsp104 ATPase and disaggregase activity.
    Torrente MP; Castellano LM; Shorter J
    PLoS One; 2014; 9(10):e110115. PubMed ID: 25299406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AAA+ Protein-Based Technologies to Counter Neurodegenerative Disease.
    March ZM; Mack KL; Shorter J
    Biophys J; 2019 Apr; 116(8):1380-1385. PubMed ID: 30952364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion aggregate structure in yeast cells is determined by the Hsp104-Hsp110 disaggregase machinery.
    O'Driscoll J; Clare D; Saibil H
    J Cell Biol; 2015 Oct; 211(1):145-58. PubMed ID: 26438827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsp104: a weapon to combat diverse neurodegenerative disorders.
    Shorter J
    Neurosignals; 2008; 16(1):63-74. PubMed ID: 18097161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disaggregases, molecular chaperones that resolubilize protein aggregates.
    Mokry DZ; Abrahão J; Ramos CH
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1273-92. PubMed ID: 26312418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-Remodeling Factors As Potential Therapeutics for Neurodegenerative Disease.
    Jackrel ME; Shorter J
    Front Neurosci; 2017; 11():99. PubMed ID: 28293166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.
    Gao X; Carroni M; Nussbaum-Krammer C; Mogk A; Nillegoda NB; Szlachcic A; Guilbride DL; Saibil HR; Mayer MP; Bukau B
    Mol Cell; 2015 Sep; 59(5):781-93. PubMed ID: 26300264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drivers of Hsp104 potentiation revealed by scanning mutagenesis of the middle domain.
    Ryan JJ; Bao A; Bell B; Ling C; Jackrel ME
    Protein Sci; 2021 Aug; 30(8):1667-1685. PubMed ID: 34010483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular Handling of Protein Aggregates by Disaggregation Machines.
    Mogk A; Bukau B; Kampinga HH
    Mol Cell; 2018 Jan; 69(2):214-226. PubMed ID: 29351843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease.
    Sharma SK; Priya S
    Cell Mol Life Sci; 2017 Feb; 74(4):617-629. PubMed ID: 27522545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.
    Lo Bianco C; Shorter J; Régulier E; Lashuel H; Iwatsubo T; Lindquist S; Aebischer P
    J Clin Invest; 2008 Sep; 118(9):3087-97. PubMed ID: 18704197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metazoan Hsp70 machines use Hsp110 to power protein disaggregation.
    Rampelt H; Kirstein-Miles J; Nillegoda NB; Chi K; Scholz SR; Morimoto RI; Bukau B
    EMBO J; 2012 Nov; 31(21):4221-35. PubMed ID: 22990239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrete roles of trehalose and Hsp104 in inhibition of protein aggregation in yeast cells.
    Sethi R; Iyer SS; Das E; Roy I
    FEMS Yeast Res; 2018 Sep; 18(6):. PubMed ID: 29860440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and function of the molecular chaperone Hsp104 from yeast.
    Grimminger-Marquardt V; Lashuel HA
    Biopolymers; 2010 Mar; 93(3):252-76. PubMed ID: 19768774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo properties of the disaggregase function of J-proteins and Hsc70 in Caenorhabditis elegans stress and aging.
    Kirstein J; Arnsburg K; Scior A; Szlachcic A; Guilbride DL; Morimoto RI; Bukau B; Nillegoda NB
    Aging Cell; 2017 Dec; 16(6):1414-1424. PubMed ID: 29024389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifespan Control by Redox-Dependent Recruitment of Chaperones to Misfolded Proteins.
    Hanzén S; Vielfort K; Yang J; Roger F; Andersson V; Zamarbide-Forés S; Andersson R; Malm L; Palais G; Biteau B; Liu B; Toledano MB; Molin M; Nyström T
    Cell; 2016 Jun; 166(1):140-51. PubMed ID: 27264606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of hsp104, a protein disaggregase.
    Sweeny EA; DeSantis ME; Shorter J
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21989490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.